Multicenter Institutional Experience of Surgically Resected Thymic Epithelial Tumors (TETs): An Observational Report on Behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone)
Tóm tắt
This multicenter analysis evaluated patient outcome and clinical pathologic features of thymic epithelial tumors after complete surgical resection and adjuvant treatment. Histologic classification and clinical staging were performed according to WHO classification and Masaoka staging system, respectively. We analyzed 62 patients, 20 (32 %) of whom had myasthenia at diagnosis. Clinical and pathologic staging was as follows: 31 (50 %) and 30 (48 %) patients had stage I disease, 19 (30 %) and 22 (35 %) stage II, 5 (8 %) and 3 (6 %) stage III, 2 (4 %) and 2 (3 %) stage IVa, and 5 (8 %) and 5 (8 %) stage IVb, respectively. Histologic examination revealed 11 (19%) type A tumors, 19 (30%) type AB tumors, 7 (12 %) type B1 tumors, 11 (17 %) type B2 tumors, 11 (17 %) type B3 tumors, and 3 (5 %) type C tumors. Adjuvant therapies comprised chemotherapy in 3 (5 %) patients and radiotherapy in 16 (26 %) patients. Median follow-up was 71 months (range 1–145). DFS and OS at 48, 60, and 72 months were 89 and 89 %, 86 and 97 %, and 95% and 92%, respectively. Myasthenia at the onset of disease (P = 0.18 for DFS; P = 0.97) and tumor size >5 cm (P = 0.94 for DFS; P = 0.56) were not prognostic factors. TETs are rare and indolent tumors. Complete surgical resection followed by adjuvant therapies, such as chemotherapy and/or radiotherapy, in patients at risk of recurrence show very good DFS and OS results, even in cases with radically resected pleural-pulmonary metastases.
Tài liệu tham khảo
Levine GD, Rosai J. Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol. 1978;9:495–515.
Lattes R. Thymomas and other tumors of the thymus: an analysis of 107 cases. Cancer. 1962;15:1224–60.
Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Talyor WF. Thymoma: a clinicopathologic review. Cancer. 1987;60:2727–43.
Loehrer PJ Sr, Wick MR. Thymic malignancies. Cancer Treat Res. 2001;105:277–302.
LeGolvan DP, Abell MR. Thymomas. Cancer. 1977;39:2142–57.
Masaoka A, Hashimoto T, Shibata K, Yamakowa Y, Nakamae K. Thymomas associated with pure red cell aplasia: histology and following studies. Cancer. 1989;64:1872.
Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485–92.
Batata MA, Martini N, Huvos AG, Aguilar RI, Beattie EJ Jr. Thymomas: clinico-pathologic features, therapy and prognosis. Cancer. 1974;34:389–96.
Monden Y, Nakahara K, Iioka S, et al. Recurrence of thymoma: clinico-pathological features, therapy, and prognosis. Ann Thorac Surg. 1985;39:165–9.
Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg. 1991;51:152–6.
Bernatz PE, Khonsari S, Harrison EG Jr, Taylor WF. Thymoma: factors influencing prognosis. Surg Clin North Am. 1973;53:885–92.
Quintanilla-Martinez L, Wilkins EW Jr, Choi N, Efird J, Hug E, Harris NL. Thymoma. Histologic subclassification is an independent prognostic factor. Cancer. 1994;74:606–17.
Sugiura H, Morikawa T, Ito K, Ono K, Okushiba S, Satoshi K, Katoh H. Long-term results of surgical treatment for invasive thymoma. Anticancer Res. 1999;19(2B):1433–7.
Curran WJ, Kornstein MJ, Brooks JJ, Turrisi AT III. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol. 1988;6:1722–7.
Haniuda M, Miyazawa M, Yoshida K, et al. Is postoperative radiotherapy for thymoma effective? Ann Surg. 1996;224:219–24.
Uematsu M, Yoshida H, Kondo M, et al. Entire hemithorax irradiation following complete resection in patients with Stage II–III invasive thymoma. Int J Radiat Oncol Biol Phys. 1996;35:357–60.
Latz D, Schraube P, Oppitz U, et al. Invasive thymoma: treatment with postoperative radiation therapy. Radiology. 1997;204:859–64.
Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1.320 patients from Japan. Ann Thorac Surg. 2003;76:878–85.
Rosai J. Histological typing of tumours of the thymus. In: WHO International histological classification of tumours, 2nd ed. New York: Springer-Verlag; 1999:5–15.
Fornasiero A, Daniele O, Ghiotto C, et al. Chemotherapy for invasive thymoma. A 13-year experience. Cancer. 1991;68(1):30–3.
Loehrer PJ Sr, Perez CA, Roth LM, Greco A, Livingston RB, Einhorn LH. Chemotherapy for advanced thymoma. Preliminary results of an intergroup study. Ann Intern Med. 1990;113:520–4.
Kaplan EL, Meier P. Nonparametric estimation of incomplete observations. J Am Stat Assoc. 1958;53:457–81.
Cox DR. Regression models and life tables. J Royal Stat Soc. 1972;34:187–220.
Okereke IC, Kesler KA, Morad MH, et al. Prognostic indicators after surgery for thymoma. Ann Thorac Surg. 2010;89:1071–7.
Monden Y, Nakahara K, Nanjo S, Fujii Y, Matsumura A, Masaoka A, Kawashima Y. Invasive thymoma with myasthenia gravis. Cancer. 1984;54:2513–8.
Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymectomy in myasthenia gravis. Results of 662 cases operated upon in 15 years. Eur J Cardio-Thorac Surg. 1989;3:504–11.
Wright CD, Wain JC, Wong DR, Donahue DM, Gaissert HA, Grillo HC, Mathisen DJ. Predictors of recurrence in thymic tumors: importance of invasion, and size. World Health Organization histology. J Thorac Cardiovasc Surg. 2005;130:1413–21.
Rieker RJ, Hoegel J, Morresi-Hauf A, Hofmann WJ, Blaeker H, Penzel R, Otto HF. Histologic classification of thymic epithelial tumors: comparison of established classification schemes. Int J Cancer. 2002;98:900–6.
Gupta R, Marchevsky AM, McKenna RJ, Wick M, Moran C, Zakowski MF, Suster S. Evidence based pathology and the pathologic evaluation of thymomas: transcapsular invasion is not a significant prognostic feature. Arch Pathol Lab Med. 2008;132:926–30.
Okereke IC, Kesler KA, Morad MH. Prognostic indicators after surgery for thymoma. Ann Thorac Surg. 2010;89:1071–9.
Lucchi M, Melfi F, Dini P, et al. Neoadjuvant chemotherapy for stage III and IV-A thymoma; a single institution experience with long term follow-up. J Thorac Oncol . 2006;1:308–13.
Okereke IC, Kesler KA, Freeman RK, et al. Thymic carcinoma: outcomes after surgical resection. Ann Thorac Surg. 2012;93:1668–72.
Bott MJ, Wang H, Travis W, et al. Management and outcomes of relapse after treatment for thymoma and thymic carcinoma. Ann Thorac Surg. 2011;92:1984–92.
Welsh JS, Wilkins KB, Green R, Bulkley G, Askin F, Diener-West M, Howard SP. Association between thymoma and second neoplasms. JAMA. 2000;283:1142–3.